Live SpaceX Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow RxSight, Inc.

Get SEC filing alerts via email and in your feed for RxSight, Inc.

RXST

RxSight, Inc.

About RxSight, Inc.

RxSight, Inc. develops innovative ophthalmic solutions, notably the Light Adjustable Lens system, to enhance post-cataract surgery visual outcomes. Its proprietary technology allows surgeons to customize and optimize vision after implantation, addressing limitations of fixed-premium intraocular lenses. Serving ophthalmologists and patients worldwide, the company focuses on improving clinical results, patient satisfaction, and practice growth through advanced, adjustable lens technology.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from RxSight, Inc.

1
1
RxSight, Inc. RxSight Reports 18.5% Revenue Decline and Increased Net Loss in Q1 2026

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
RxSight, Inc. RxSight Reports $134.5 Million in Sales for 2025, Faces Increased Losses

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
RxSight, Inc. RxSight Reports Decline in Q3 Sales and Increased Net Losses for 2025

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
RxSight, Inc. RxSight Reports Decrease in Q2 Sales and Increased Operating Losses Despite Revenue Growth in First Half of 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
RxSight, Inc. RxSight Reports 28.4% Revenue Growth to $37.9 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
RxSight, Inc. RxSight Reports Significant Financial Growth, Net Loss in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments